ARTICLE | Company News

Actelion, Theratechnologies sales and marketing update

February 27, 2012 8:00 AM UTC

Theratechnologies granted Actelion's Actelion Pharmaceuticals Canada Inc. unit exclusive rights to commercialize tesamorelin in Canada. Actelion will be responsible for all regulatory activities, while Theratechnologies will manufacture and supply tesamorelin to Actelion at an undisclosed price. Terms were not disclosed. ...